Comparable Effects of Strontium Ranelate and Alendronate Treatment on Fracture Reduction in a Mouse Model of Osteogenesis Imperfecta

Alendronate (Aln) has been the first-line drug for osteogenesis imperfecta (OI), while the comparable efficacy of Aln and strontium ranelate (SrR) remains unclear. This study is aimed at comparing the effects of SrR and Aln treatment in a mouse model of OI. Three-week-old oim/oim and wt/wt female mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Changgui, Sun, Bin, Ma, Chao, Wu, Huiqiao, Chen, Rui, He, Hailong, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810565/
https://www.ncbi.nlm.nih.gov/pubmed/33506016
http://dx.doi.org/10.1155/2021/4243105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810565/
https://www.ncbi.nlm.nih.gov/pubmed/33506016
http://dx.doi.org/10.1155/2021/4243105

Ejemplares similares